TABLE 2.
Ipsilateral VGluT2-positive projections to the anterior versus posterior PVN and its surround. Values are shown for each individual anterior-to-mid (90, 110, and 112) and posterior-to-mid (102, 104, and 109) PVN case, as well as for the mean of each group
| Case 90 |
Case 110 |
Case 112 |
Case 102 |
Case 104 |
Case 109 |
Anterior Cases (Mean ± SEM) |
Posterior Cases (Mean ± SEM) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #FG | % | #FG | % | #FG | % | #FG | % | #FG | % | #FG | % | #FG | % | #FG | % | |
| BST | ||||||||||||||||
| BSTad | 34 | 0 | 25 | 0 | 15 | 0 | 0 | 0 | 5 | 0 | 12 | 0 | 25 ± 7 | 0±0 | 6±4 | 0±0 |
| BSTav | 34 | 0 | 17 | 0 | 16 | 0 | 37 | 14 | 11 | 0 | 12 | 0 | 22 ± 7 | 0±0 | 20 ± 10 | 5±6 |
| BSTif/v | 99 | 0 | 14 | 0 | 14 | 0 | 4 | 25 | 40 | 13 | 17 | 18 | 42 ± 35 | 0±0 | 20 ± 13 | 18 ± 4 |
| BSTpr | 24 | 0 | 18 | 0 | 7 | 0 | 6 | 0 | 8 | 25 | 9 | 22 | 16 ± 6 | 0±0 | 8±1 | 16 ± 10 |
| Hypothalamus | ||||||||||||||||
| AHA | 65 | 0 | 62 | 2 | 21 | 0 | 0 | 0 | 5 | 0 | 14 | 21 | 49 ± 17 | 1±1 | 6±5 | 7±9 |
| AHNa | 30 | 3 | 17 | 12 | 17 | 18 | 35 | 37 | 14 | 43 | 5 | 0 | 21 ± 5 | 11 ± 5 | 18 ± 11 | 27 ± 16 |
| AHNc | 149 | 4 | 68 | 6 | 39 | 15 | 23 | 39 | 77 | 22 | 58 | 5 | 85 ± 40 | 8±4 | 53 ± 19 | 22 ± 12 |
| AHNp | 11 | 0 | 7 | 0 | 14 | 0 | 15 | 13 | 11 | 0 | 7 | 14 | 11 ± 2 | 0±0 | 11 ± 3 | 9±6 |
| ARC | 6 | 0 | 18 | 6 | 25 | 0 | 3 | 67 | 2 | 0 | 3 | 0 | 16 ± 7 | 2±2 | 3±0 | 22 ± 27 |
| DMHa | 16 | 0 | 5 | 0 | 17 | 6 | 36 | 31 | 11 | 45 | 11 | 9 | 13 ± 5 | 2±2 | 19 ± 10 | 28 ± 13 |
| DMHp | 7 | 0 | 4 | 0 | 4 | 0 | 16 | 38 | 0 | 0 | 4 | 0 | 5±1 | 0±0 | 7±6 | 13 ± 15 |
| DMHv | 0 | 0 | 4 | 0 | 11 | 27 | 6 | 50 | 5 | 100 | 9 | 67 | 5±4 | 9 ± 11 | 7±1 | 72 ± 18 |
| LHA | 310 | 0 | 104 | 6 | 101 | 6 | 167 | 28 | 164 | 31 | 128 | 22 | 172 ± 85 | 4±2 | 153 ± 15 | 27 ± 3 |
| LPO | 13 | 8 | 12 | 8 | 1 | 0 | 13 | 8 | 30 | 17 | 28 | 7 | 9±5 | 5±3 | 24 ± 7 | 11 ± 4 |
| MePO | 25 | 8 | 1 | 0 | 4 | 0 | 1 | 100 | 7 | 43 | 11 | 18 | 10 ± 9 | 3±3 | 6±4 | 54 ± 30 |
| MPO | 96 | 0 | 44 | 0 | 35 | 0 | 59 | 8 | 15 | 20 | 28 | 18 | 58 ± 23 | 0±0 | 34 ± 16 | 15 ± 4 |
| MPN | 111 | 1 | 90 | 1 | 96 | 15 | 19 | 26 | 8 | 13 | 34 | 3 | 99 ± 8 | 6±6 | 20 ± 9 | 14 ± 8 |
| PH | 30 | 0 | 16 | 0 | 11 | 0 | 45 | 49 | 34 | 74 | 95 | 58 | 19 ± 7 | 0±0 | 58 ± 23 | 60 ± 9 |
| PM | na | na | na | na | na | 18 | 89 | na | 18† | 89† | ||||||
| PV | 22 | 0 | 9 | 0 | 9 | 0 | 0 | 0 | 2 | 0 | 3 | 33 | 13 ± 5 | 0±0 | 2±1 | 11 ± 14 |
| RCH | 19 | 0 | 25 | 0 | 11 | 0 | 8 | 0 | 8 | 25 | 6 | 0 | 18 ± 5 | 0±0 | 7±1 | 8 ± 10 |
| SCH | 9 | 0 | 41 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 14 | 14 | 20 ± 13 | 0±0 | 5±6 | 5±6 |
| Tub | 10 | 0 | 16 | 6 | 15 | 0 | 8 | 25 | 6 | 0 | 5 | 40 | 14 ± 2 | 2±3 | 6±1 | 22 ± 14 |
| VMHc | 65 | 18 | 30 | 40 | 21 | 10 | 16 | 81 | 22 | 91 | 15 | 60 | 39 ± 16 | 23 ± 11 | 18 ± 3 | 77 ± 11 |
| VMHdm | 61 | 13 | 32 | 44 | 23 | 26 | 29 | 72 | 18 | 72 | 36 | 81 | 39 ± 14 | 28 ± 11 | 28 ± 6 | 75 ± 4 |
| VMHvl | 35 | 20 | 46 | 30 | 17 | 29 | 24 | 71 | 19 | 95 | 6 | 100 | 33 ± 10 | 27 ± 4 | 16 ± 7 | 89 ± 11 |
| Other sites | ||||||||||||||||
| MeA | 148 | 1 | 41 | 10 | 36 | 0 | 5 | 80 | 47 | 47 | 28 | 29 | 75 ± 45 | 3±4 | 27 ± 15 | 52 ± 18 |
| LS | 5 | 0 | 24 | 0 | na | na | 58 | 0 | 142 | 0 | 15† | 0† | 100† | 0† | ||
| PVT | 18 | 28 | 2 | 0 | 13 | 0 | 8 | 100 | 18 | 72 | 45 | 73 | 11 ± 6 | 9 ± 11 | 24 ± 14 | 82 ± 11 |
| SI | 13 | 0 | 11 | 0 | 4 | 0 | 9 | 11 | 47 | 21 | 32 | 16 | 9±3 | 0±0 | 29 ± 14 | 16 ± 4 |
| ZI | 126 | 1 | 1 | 0 | 8 | 0 | 49 | 0 | 102 | 3 | 87 | 5 | 45 ± 50 | 0±0 | 79 ± 19 | 3±2 |
#FG denotes the number of FG-positive cell bodies observed in each forebrain region. % denotes the percentage of these FG-positive cell bodies that co-expressed VGluT2 mRNA. na denotes not available.
†
denotes that the n was insufficient to permit calculation of the SEM.